Any Questions? info@beandbyias.com /+91 9958826967, 9958294810

For registration call @ 9958294810 or mail at info@beandbyias.com | Law Optional for Civil Services & Judicial Services Live classes Starting from 12th October 2020. |

Thalassemia Bal Sewa Yojna

Thalassemia Bal Sewa Yojna

Context:

Union Ministery for Health and Family Welfare has launched the second phase of “Thalassemia Bal Sewa Yojna” for the underprivileged Thalassemic patients.

  • Objective: To provide a one-time cure opportunity for Haemoglobinopathies like Thalassaemia and Sickle Cell Disease for patients who have a matched family donor.
  • Eligibility: Only those patients are eligible whose monthly family income is below Rs 20,000.
  • The scheme has been extended to cover Aplastic Anaemia patients (lack of blood cell production in the body).

Hematopoietic Stem Cell:

  • It is an immature cell that can develop into all types of blood cells, including white blood cells, red blood cells, and platelets. Hematopoietic stem cells are found in the peripheral blood and the bone marrow. 
  • The outcome of Hematopoietic Stem Cell Transplantation (HSCT) for thalassemia major depends on several factors other than the type of donor.
  • It was first explored in humans in the 1950s and was based on observational studies in mice models.

The Hematopoietic Stem Cell Transplantation (HSCT) program:

  • It mainly refers to the transplantation of stem cells from various sources (bone marrow, growth factor-stimulated peripheral blood, and umbilical cord blood) for the treatment of various diseases like autoimmune, and genetic diseases.
  • The program was launched in 2017 and is funded by Coal India Corporate Social Responsibility (CSR).
  • The program will be extended for the next two years from 2020.

Thalassemia: